BIGHAT BIOSCIENCES
BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.
BIGHAT BIOSCIENCES
Industry:
Artificial Intelligence (AI) Biotechnology Medical Therapeutics
Founded:
2019-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.bighatbio.com
Total Employee:
51+
Status:
Active
Contact:
650-489-1337
Email Addresses:
[email protected]
Total Funding:
99.3 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Google Maps Content Delivery Network Global Site Tag JsDelivr Google Analytics 4
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
PredxBio
PredxBio is a computational pathology company developing AI tools to analyze whole slide image pathology samples based on spatial analytics.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Veyetals
Veyetals is a mobile application that helps to measures stress levels and blood pressure using artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-03-28 | Frugi Biotechnology | Frugi Biotechnology acquired by BigHat Biosciences | N/A |
Investors List
Gaingels
Gaingels investment in Series B - BigHat Biosciences
8VC
8VC investment in Series B - BigHat Biosciences
Andreessen Horowitz
Andreessen Horowitz investment in Series B - BigHat Biosciences
Amgen Ventures
Amgen Ventures investment in Series B - BigHat Biosciences
Bristol-Myers Squibb
Bristol-Myers Squibb investment in Series B - BigHat Biosciences
Quadrille Capital
Quadrille Capital investment in Series B - BigHat Biosciences
GRIDS Capital
GRIDS Capital investment in Series B - BigHat Biosciences
AME Cloud Ventures
AME Cloud Ventures investment in Series B - BigHat Biosciences
Section 32
Section 32 investment in Series B - BigHat Biosciences
Innovation Endeavors
Innovation Endeavors investment in Series A - BigHat Biosciences
Official Site Inspections
http://www.bighatbio.com Semrush global rank: 2.88 M Semrush visits lastest month: 5.69 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "BigHat Biosciences"
About - BigHat Bio
We are an interdisciplinary, STEM-focused team supported by experienced leaders, world-class advisors, and top-notch investors.See details»
BigHat Biosciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number 650-489-1337 BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules …See details»
BigHat Biosciences - LinkedIn
BigHat Biosciences | 8,441 followers on LinkedIn. BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform | BigHat’s mission is to ...See details»
BigHat Biosciences
Before BigHat he was Senior Director of Engineering at GoDaddy, where he led an organization focused on automation and security and drove the transformation to a cloud native architecture. Previously, he created a web-scale analytics …See details»
AI-Created Antibodies Drive Innovation at BigHat …
Oct 25, 2023 “It’s why we can pursue so many therapeutic programs in parallel in a lean organization.” 1, 2. Milliner platform overview: a full-stack antibody discovery and design [BigHat Biosciences]See details»
BigHat Biosciences Raises $75 Million in Series B …
Jul 20, 2022 SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a biotechnology company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today ...See details»
BigHat Biosciences Raises $19 Million in Series A Funding
Feb 10, 2021 Read original article at BusinessWire. SAN CARLOS, Calif.–(February 10,2021)–BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, today …See details»
BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its ...
May 11, 2022 08:01 AM Eastern Daylight Time. SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a biotechnology company designing safer, more effective next-generation …See details»
AbbVie and BigHat Biosciences Announce Research Collaboration …
Dec 5, 2023 To learn more about us, visit https://www.bighatbio.com and follow @BigHatBio on LinkedIn and Twitter. Forward-Looking Statements Some statements in this news release are, …See details»
BigHat Biosciences Enters Into Strategic Collaboration to Leverage ...
Apr 24, 2024 To learn more about us, visit https://www.bighatbio.com and follow @BigHatBio on LinkedIn and Twitter. Contacts. BigHat Biosciences Elizabeth Schwarzbach …See details»
BigHat Biosciences Enters Into Strategic Collaboration to Leverage ...
SAN MATEO, Calif., April 24, 2024--BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform …See details»
Our technology & Science - BigHat Bio
Yet, we’ve only scratched the surface of what biologic drugs can do in fighting disease because clinical-grade antibodies also come with challenges – they must have high affinity and …See details»
BigHat Biosciences Appoints Rob Chess, Serial ... - Business Wire
May 11, 2022 SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a biotechnology company designing safer, more effective next-generation antibody therapies for patients using …See details»
BigHat Biosciences Raises $19 Million in Series A Funding to …
Feb 10, 2021 SAN CARLOS, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, today …See details»
transformative Therapeutics - BigHat Bio
We develop transformative antibody therapeutics for patients, with a current focus on oncology, inflammatory diseases, and immunology. We match disease biology and therapeutic targets …See details»
BigHat Biosciences Announces Research Collaboration with Merck
Nov 29, 2022 SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, Inc., a biotechnology company with a machine learning-guided antibody discovery and development …See details»
BMS、安进同时押注，这家AI+抗体新锐有什么特色？ - 知乎
图：BigHatB轮投资机构名单. 据智药局研究，该公司创始人也大有来头，为Broad研究所医学遗传学联席主任、前谷歌-AI基因组学负责人Mark DePristo。 自2019年成立至今，累计融资1亿美 …See details»
BigHat Biosciences Completes First Stage of Research …
Jan 11, 2022 BigHat Biosciences, Inc., a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform,See details»
Newsroom - BigHat Bio
BigHat Biosciences Enters into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & DesignSee details»